OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells remains a paramount challenge to the biopharmaceutical industry. Multiple strategies have been employed to antibody titer, comprising process parameter optimization, cell line development, and implementation of perfusion technologies. Fine-tuning growth param